D
Ducgiang Chemicals Group JSC
VN:DGC
Ducgiang Chemicals Group JSC
VN:DGC
Price:
118 500
VND
1.72%
Market Cap:
45T
VND
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
DGC Alert
Ducgiang Chemicals Group JSC
118500
+2000 (+1.72%)
| 52 Week Range |
88 000
131 800
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Ducgiang Chemicals Group JSC
Balance Sheet
Balance Sheet Decomposition
Ducgiang Chemicals Group JSC
Ducgiang Chemicals Group JSC
| Current Assets | 13T |
| Cash & Short-Term Investments | 11.4T |
| Receivables | 655.5B |
| Other Current Assets | 1T |
| Non-Current Assets | 3.2T |
| PP&E | 2.4T |
| Intangibles | 404.5B |
| Other Non-Current Assets | 378.7B |
| Current Liabilities | 2T |
| Accounts Payable | 221.7B |
| Accrued Liabilities | 646.8B |
| Short-Term Debt | 791.6B |
| Other Current Liabilities | 327.9B |
| Non-Current Liabilities | 458.8B |
| Other Non-Current Liabilities | 458.8B |
Balance Sheet
Ducgiang Chemicals Group JSC
Ducgiang Chemicals Group JSC
Currency: VND
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
8 392
|
10 915
|
19 982
|
82 619
|
274 287
|
127 680
|
282 320
|
123 958
|
1 535 475
|
1 060 575
|
|
| Cash |
8 392
|
10 915
|
3 582
|
4 519
|
19 462
|
67 634
|
39 192
|
114 958
|
276 975
|
48 075
|
|
| Cash Equivalents |
0
|
0
|
16 400
|
78 100
|
254 825
|
60 045
|
243 128
|
9 000
|
1 258 500
|
1 012 500
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
245 600
|
642 746
|
1 557 535
|
3 631 680
|
7 471 319
|
9 342 001
|
|
| Total Receivables |
757 850
|
598 776
|
174 438
|
240 710
|
781 220
|
633 376
|
838 398
|
775 213
|
764 677
|
1 067 115
|
|
| Accounts Receivables |
89 446
|
130 119
|
55 142
|
143 667
|
708 965
|
566 659
|
750 356
|
630 346
|
514 033
|
712 694
|
|
| Other Receivables |
668 404
|
468 657
|
119 296
|
97 043
|
72 255
|
66 717
|
88 043
|
144 866
|
250 644
|
354 421
|
|
| Inventory |
156 234
|
177 667
|
31 202
|
34 561
|
796 639
|
808 254
|
697 143
|
1 386 432
|
999 984
|
854 909
|
|
| Other Current Assets |
21 467
|
39 999
|
7 500
|
12 961
|
37 996
|
50 922
|
58 103
|
80 065
|
213 839
|
142 048
|
|
| Total Current Assets |
943 943
|
827 356
|
233 123
|
370 851
|
2 135 742
|
2 262 978
|
3 433 499
|
5 997 348
|
10 985 294
|
12 466 647
|
|
| PP&E Net |
545 925
|
590 152
|
49 172
|
46 357
|
2 391 997
|
2 245 188
|
2 209 714
|
2 145 311
|
2 014 719
|
2 358 366
|
|
| PP&E Gross |
545 925
|
590 152
|
49 172
|
46 357
|
2 391 997
|
2 245 188
|
2 209 714
|
2 145 311
|
2 014 719
|
2 358 366
|
|
| Accumulated Depreciation |
243 084
|
313 053
|
78 888
|
88 736
|
1 009 975
|
1 265 288
|
1 521 226
|
1 802 529
|
2 071 240
|
2 534 989
|
|
| Intangible Assets |
52 889
|
51 598
|
258
|
213
|
113 000
|
110 029
|
107 163
|
156
|
92
|
10 746
|
|
| Goodwill |
0
|
0
|
0
|
0
|
5 377
|
4 825
|
4 274
|
3 722
|
3 171
|
313 036
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9 239
|
28 964
|
31 225
|
|
| Long-Term Investments |
99 230
|
317 417
|
439 282
|
439 282
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
35 189
|
48 013
|
206
|
29 728
|
83 880
|
98 835
|
121 501
|
364 618
|
372 942
|
355 886
|
|
| Other Assets |
0
|
0
|
0
|
0
|
5 377
|
4 825
|
4 274
|
3 722
|
3 171
|
313 036
|
|
| Total Assets |
1 677 175
N/A
|
1 834 537
+9%
|
722 041
-61%
|
886 431
+23%
|
4 729 996
+434%
|
4 721 857
0%
|
5 876 150
+24%
|
8 520 393
+45%
|
13 405 183
+57%
|
15 535 906
+16%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
110 330
|
117 000
|
24 393
|
67 797
|
205 791
|
130 370
|
137 024
|
683 398
|
326 043
|
190 111
|
|
| Accrued Liabilities |
81 651
|
96 993
|
35 340
|
35 251
|
167 325
|
182 781
|
186 072
|
238 222
|
381 593
|
572 402
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1 133 082
|
735 171
|
1 148 974
|
841 909
|
467 625
|
1 328 013
|
|
| Current Portion of Long-Term Debt |
453 427
|
332 674
|
7 565
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
97 779
|
93 865
|
14 686
|
117 189
|
58 375
|
221 875
|
336 549
|
424 762
|
1 396 168
|
1 402 381
|
|
| Total Current Liabilities |
743 187
|
640 531
|
81 984
|
220 237
|
1 564 573
|
1 270 197
|
1 808 619
|
2 188 291
|
2 571 429
|
3 492 907
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15 790
|
|
| Minority Interest |
303 972
|
350 557
|
0
|
0
|
122 671
|
127 550
|
156 439
|
255 335
|
382 447
|
330 299
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
100
|
100
|
100
|
100
|
271
|
|
| Total Liabilities |
1 047 159
N/A
|
991 089
-5%
|
81 984
-92%
|
220 237
+169%
|
1 687 244
+666%
|
1 397 847
-17%
|
1 965 158
+41%
|
2 443 726
+24%
|
2 953 976
+21%
|
3 839 267
+30%
|
|
| Equity | |||||||||||
| Common Stock |
334 994
|
422 091
|
500 089
|
500 089
|
1 078 038
|
1 293 636
|
1 487 669
|
1 710 806
|
3 797 793
|
3 797 793
|
|
| Retained Earnings |
127 257
|
240 328
|
37 381
|
59 781
|
913 545
|
835 698
|
1 139 905
|
2 946 707
|
5 083 857
|
5 988 746
|
|
| Additional Paid In Capital |
1 072
|
1 072
|
1 072
|
1 072
|
1 786 667
|
1 786 667
|
1 786 667
|
1 786 667
|
1 786 667
|
1 786 667
|
|
| Treasury Stock |
3
|
4
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
|
| Other Equity |
166 696
|
179 961
|
101 523
|
105 261
|
735 489
|
591 983
|
503 241
|
367 504
|
217 102
|
123 441
|
|
| Total Equity |
630 016
N/A
|
843 448
+34%
|
640 056
-24%
|
666 194
+4%
|
3 042 752
+357%
|
3 324 010
+9%
|
3 910 992
+18%
|
6 076 667
+55%
|
10 451 206
+72%
|
11 696 639
+12%
|
|
| Total Liabilities & Equity |
1 677 175
N/A
|
1 834 537
+9%
|
722 041
-61%
|
886 431
+23%
|
4 729 996
+434%
|
4 721 857
0%
|
5 876 150
+24%
|
8 520 393
+45%
|
13 405 183
+57%
|
15 535 906
+16%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
46
|
66
|
165
|
165
|
356
|
371
|
371
|
371
|
380
|
380
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
